Zacks Investment Management Amphastar Pharmaceuticals, Inc. Transaction History

Zacks Investment Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$44.49 - $62.93 $75,944 - $107,421	-1,707 Reduced 7.77%	20,268 $1.25 Million
Q3 2023 Nov 14, 2023	BUY	$45.51 - $65.0 $58,662 - $83,785	1,289 Added 6.23%	21,975 $1.01 Million
Q2 2023 Aug 15, 2023	BUY	$35.77 - $58.38 $123,227 - $201,119	3,445 Added 19.98%	20,686 $1.19 Million
Q2 2023 Aug 14, 2023	BUY	$35.77 - $58.38 $616,710 - $1.01 Million	17,241 New	17,241 $990,000

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.